Spinal cord injury (SCI) remains one of the most devastating medical conditions, severely impacting quality of life and often ...

NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

In a groundbreaking development that could change the lives of thousands of people with spinal cord injuries, European ...

Antibody NG101 enhances motor recovery in spinal cord injury patients, marking progress in rehabilitation research.

Spinal tumors in children are very rare. They can be malignant (cancerous) or benign (non cancerous). As spine tumors grow, they can put pressure on the spinal cord, resulting in neurologic symptoms.

These nerves send signals for things like pressure, pain, temperature, and texture from your skin to the spinal cord and brain. Because a dermatome identifies a specific area of the body with a ...

Kessler Foundation researchers have developed robust measures of neighborhood economic factors to study how social determinants influence health outcomes after spinal cord injury (SCI).

The new technique is intended for people with spinal cord injuries where the connection between their brain and spinal cord has not been totally severed, and who still have some movement in their ...

Neural stem cell transplants prove safe in chronic spinal injuries, showing promise for restoring motor and sensory function.

A new electrically active transplantable material that can help to regrow cells in the brain and spinal cord could redefine ...